Monday, December 23, 2024
HomeTagsSARS-CoV-2

SARS-CoV-2

Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant

Brii Biosciences Limited , a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced new...

Roche has rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant

Roche and TIB Molbiol, a newly acquired subsidiary within the Roche Diagnostics division, have added three additional Research Use Only (RUO) test kits for...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics